Hurvitz Chaim 4
4 · NRX Pharmaceuticals, Inc. · Filed Sep 10, 2025
Insider Transaction Report
Form 4
Hurvitz Chaim
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-09+25,000→ 25,000 totalExercise: $1.73Exp: 2035-04-09→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer.